Nonoperating Income (Expense) in USD of Biostax Corp. from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biostax Corp. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2012 to Q2 2024.
  • Biostax Corp. Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was -$128K, a 91.6% decline year-over-year.
  • Biostax Corp. Nonoperating Income (Expense) for the twelve months ending 30 Jun 2024 was -$1.01M, a 53.2% increase year-over-year.
  • Biostax Corp. annual Nonoperating Income (Expense) for 2023 was -$878K, a 63% increase from 2022.
  • Biostax Corp. annual Nonoperating Income (Expense) for 2022 was -$2.37M, a 155% decline from 2021.
  • Biostax Corp. annual Nonoperating Income (Expense) for 2021 was $4.32M, a 74.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Biostax Corp. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.01M -$128K -$61.2K -91.6% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 -$951K -$87.3K -$73K -511% 01 Jan 2024 31 Mar 2024 10-Q/A 19 Aug 2024
Q4 2023 -$878K -$760K -$750K -7482% 01 Oct 2023 31 Dec 2023 10-K/A 05 Jul 2024
Q3 2023 -$128K -$36.4K +$2.04M +98.2% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 -$2.16M -$66.8K -$2.15M -103% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$11.9K -$14.3K +$2.36M +99.4% 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024
Q4 2022 -$2.37M -$10K +$47.7K +82.6% 01 Oct 2022 31 Dec 2022 10-K/A 05 Jul 2024
Q3 2022 -$2.42M -$2.07M -$5.3M -164% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $2.88M $2.08M +$2.01M +2623% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 $871K -$2.37M -$3.45M -320% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $4.32M -$57.7K +$509K +89.8% 01 Oct 2021 31 Dec 2021 10-K 10 Apr 2023
Q3 2021 $3.82M $3.23M -$998K -23.6% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $4.81M $76.6K +$862K 01 Apr 2021 30 Jun 2021 10-Q 24 Aug 2022
Q1 2021 $3.95M $1.08M +$1.48M 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $2.48M -$567K -$990K -234% 01 Oct 2020 31 Dec 2020 10-K 18 Mar 2022
Q3 2020 $3.47M $4.23M +$4.78M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$1.31M -$786K -$458K -140% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$854K -$398K -$295K -288% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q4 2019 -$559K $424K +$500K 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2021
Q3 2019 -$1.06M -$552K +$1.4M +71.7% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$2.46M -$327K +$2.44M +88.2% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$4.9M -$102K -$359K -140% 01 Jan 2019 31 Mar 2019 10-Q 30 Jun 2020
Q4 2018 -$4.54M -$76K +$2.12M +96.5% 01 Oct 2018 31 Dec 2018 10-K/A 28 Aug 2020
Q3 2018 -$6.66M -$1.95M -$1.8M -1196% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 -$4.86M -$2.77M -$4.29M -283% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$574K $256K +$1.45M 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019
Q4 2017 -$2.02M -$2.2M -$959K -77.5% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019
Q3 2017 -$1.06M -$151K +$1.1M +88% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$2.16M $1.52M +$2.91M 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$5.07M -$1.19M +$476K +28.6% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$5.55M -$1.24M -$1.72M -355% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 -$3.83M -$1.25M +$222K +15% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$4.05M -$1.39M -$1.25M -900% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$2.79M -$1.67M -$1.65M -9131% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$1.15M $485K +$759K 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$1.91M -$1.47M +$2.64M +64.2% 01 Jul 2015 30 Sep 2015 10-Q 15 Nov 2016
Q2 2015 -$4.55M -$139K -$18.2K -15% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$4.53M -$18K +$144K +88.9% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$4.67M -$274K +$1.6M +85.4% 01 Oct 2014 31 Dec 2014 10-K/A 16 May 2016
Q3 2014 -$6.27M -$4.12M -$3.91M -1904% 01 Jul 2014 30 Sep 2014 10-Q/A 22 Dec 2015
Q2 2014 -$2.36M -$121K +$4.57M +97.4% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$6.93M -$162K +$3.15M +95.1% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$10.1M -$1.87M 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$205K 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$4.69M 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$3.31M -$3.3M -48906% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q1 2012 -$6.75K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013

Biostax Corp. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$878K +$1.49M +63% 01 Jan 2023 31 Dec 2023 10-K/A 05 Jul 2024
2022 -$2.37M -$6.7M -155% 01 Jan 2022 31 Dec 2022 10-K/A 05 Jul 2024
2021 $4.32M +$1.85M +74.7% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023
2020 $2.48M +$3.03M 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022
2019 -$559K +$3.98M +87.7% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021
2018 -$4.54M -$2.52M -125% 01 Jan 2018 31 Dec 2018 10-K/A 28 Aug 2020
2017 -$2.02M +$3.53M +63.6% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 -$5.55M -$4.4M -384% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 -$1.15M +$3.53M +75.5% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$4.67M +$5.4M +53.6% 01 Jan 2014 31 Dec 2014 10-K/A 16 May 2016
2013 -$10.1M +$12.1M +54.5% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$22.1M 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.